<DOC>
	<DOC>NCT00306917</DOC>
	<brief_summary>Prospective, randomized study of Summit Porocoat versus Summit DuoFix HA in total hip arthroplasty</brief_summary>
	<brief_title>Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement</brief_title>
	<detailed_description>Hydroxyapatite (HA) is a bioactive ceramic that resembles the natural inorganic mineral content of bone, and as such is a highly osteoconductive material. The purpose of this study is to compare an HA coated and uncoated prosthesis.</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<criteria>Primary total hip replacement Patient age less than or equal to 75 Sufficient bone stock to support prosthesis Previous hip replacement Significant angular/bony deformity Active joint sepsis Metal allergy Renal transplant Psychosocial disease Neurological disease/musculoskeletal disease that may affect weightbearing</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Total Hip Replacement</keyword>
</DOC>